维普期刊资源整合服务平台（V6.5）

74篇 您的检索式：作者名="Groot PG"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Clinical consequences of antiphospholipid antibodies显示文摘	Derksen RH de Groot PG	2004	Neth J Med2004，62，8：	1
2	Autoantibodies directed against domain Iof beta2-glycoprotein I 显示文摘	de Laat B de Groot PG	2011	Curr Rheumatol Rep2011，13，1：	1
3	Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses 显示文摘	van Holten TC Waanders LF de Groot PG	2013	PLoS One2013，8，62：	1
4	Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI l显示文摘	Meltzer ME Lisman T de Groot PG	2010	Blood2010，116，1：	1
5	The complexity of the phospholipid binding protein Annexin V 显示文摘	van Heerde WL de Groot PG Reutelingsperger CP	1995	Thromb Haemost1995，73，2：	1
6	Lupus anticoagu-lants and the risk of a first episode of deep venous thrombosis 显示文摘	DE GROOT PG LUTTERS B DERKSEN RH	2005	JThromb Haemost2005，3，：	1
7	Anti - phospholipid antibodies : update on detection, pathophysiology, and treatment 显示文摘	de Groot PG Derksen RH	2004	Curr Opin Hematol2004，11，3：	1
8	Catastrophic antiphospholipid syndrome:international consensus statement on classification criteria and treatment guidelines显示文摘	Asherson RA Cervera R de Groot PG	2003	Lupus2003，12，7：	1
9	Enhanced Ca^2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: Potential link between contractile adaptation and arrhythmogenesis显示文摘	Sipido KR Voiders PG de Groot SH	2000	Circulation2000，102，17：	1
10	Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment显示文摘	Minnema MC Fijnheer R De Groot PG	2003	J Thromb Haemost2003，1，3：	1
11	The significance of autoantibodies against beta2-glycoprotein I显示文摘	de Groot PG Urbanus RT	2012	Blood2012，120，2：	1
12	No evidence for an intrinsic platelet defect in patients with liver cirrhosis-studies under flow conditions显示文摘	Lisman T Adelmeijer J de Groot PG	2006	J Thromb Haemost2006，4，9：	1
13	Fluctuation of anticardiolipin antibody levels in patients with systemic lupus eryth-matoaus: a prospective study 显示文摘	Out HJ de Groot PG Hasselaar P	1989	Ann Rheum Dis1989，48，12：	1
14	Localization of a gene for human alpha-galactosidase B(=N-acetyl-alpha-D-galactosaminidase) on chromosome 22显示文摘	Westerveld A Meera Khan P	1978	Hum Genet1978，44，：	1
15	β2-glycoprotein I:a novel component of innate immu-nity显示文摘	Agar C de Groot PG Mrgelin M Monk SD van Os G Levels JH	2011	Blood2011，117，25：	1
16	β2-Glycoprotein I:evolution,structure and function显示文摘	de Groot PG Meijers JC	2011	J Thromb Haemost2011，9，7：	1
17	The impact of the fibrinolytic system on the risk of venous and arterial thrombosis显示文摘	Meltzer ME Doggen C J Groot PG	2009	Semin Thromb Hemost2009，35，5：	1
18	The antiphospholipid syndrome:clinicalcharacteristics,laboratory features and pathogenesis显示文摘	Groot PG Derksen RH	2005	Curr OpinInfect Dis2005，18，3：	1
19	Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI- 1 显示文摘	Mehzer ME Lisman T de Groot PG	2010	Blood2010，116，：	1
20	Extremely high levels of yon Willebrand factor antigen and of procoagulant factor Ⅷ found in multiple myeloma patients are associated with activity status but not with thalidomide treatment显示文摘	Minnema MC Fijnheer R De Groot PG	2003	J Thromb Haemost2003，1，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示